<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1364</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Import substitution and localization results in Russia, 2017</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bespalov</surname><given-names>Nikolai</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">RNC Pharma</aff><pub-date date-type="epub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><issue>13S</issue><fpage>162</fpage><lpage>168</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2018,</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract>In 2017, the Russian pharmaceutical industry slowed down markedly in growth. 4.5 bil. drug packs were produced for a total of RUB 333.6 bil. in our country at the end of 2017 (at producers' prices, including VAT). At the same time, the dynamics of drug production in terms of rubles amounted to only 6.1%, which is four times lower than the indices recorded during the previous two years. The natural growth rate demonstrated a negative trend at the end of 2017 (-0,3 %).</abstract><kwd-group xml:lang="en"><kwd>RNC Pharma</kwd><kwd>MDU</kwd><kwd>Russian pharmaceutical industry</kwd><kwd>INN</kwd><kwd>VED</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ЛП</kwd><kwd>Фармасинтез</kwd><kwd>фармрынок</kwd></kwd-group></article-meta></front><body></body><back/></article>
